Insights into biochemical and genetical basis of glucokinase activation from naturally occuring hypoglycaemia mutations

Insights into biochemical and genetical basis of glucokinase activation from naturally occuring hypoglycaemia mutations

Bibliographische Detailangaben
Hauptverfasser:	Gloyn, A, Noordam, L, Willemsen, M, Ellard, S, Lam, W, Shiota, C, Magnuson, M, Matschinsky, F, Hattersley, A
Format:	Conference item
Veröffentlicht:	2003

Ähnliche Einträge

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
von: Gloyn, A, et al.
Veröffentlicht: (2003)

Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
von: Ding, S, et al.
Veröffentlicht: (2010)

Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans.
von: van de Bunt, M, et al.
Veröffentlicht: (2008)

Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
von: Gloyn, A, et al.
Veröffentlicht: (2005)

Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia
von: Beer, N, et al.
Veröffentlicht: (2010)

Familial persistent hyperinsulinaemic hypoglycaemia of infancy due to a novel glucokinase (GCK) activating mutation G68V
von: Gloyn, A, et al.
Veröffentlicht: (2006)

Persistent hyperinsulinemic hypoglycaemia in a 7 yr old girl due to a novel activating glucokinase mutation
von: Wabitsch, M, et al.
Veröffentlicht: (2006)

Phenotypic heterogeneity in a family with a novel activating glucokinase (GCK) mutation (G68V) causing familial persistent hyperinsulinaemic hypoglycaemia of infancy
von: Gloyn, A, et al.
Veröffentlicht: (2007)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
von: Thomson, K, et al.
Veröffentlicht: (2003)

Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
von: Gloyn, A, et al.
Veröffentlicht: (2002)

Investigating novel mutational mechanisms for glucokinase mutations with near normal or paradoxical kinetics
von: Tribble, N, et al.
Veröffentlicht: (2009)

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
von: Gloyn, A, et al.
Veröffentlicht: (2007)

Clinical characteristics of subjects with a missense mutation in glucokinase.
von: Page, R, et al.
Veröffentlicht: (1995)

Catalytic instability of the glucokinase MODY-2 mutants V62M and G72R in pancreatic beta cells
von: Arden, C, et al.
Veröffentlicht: (2006)

Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
von: Turkkahraman, D, et al.
Veröffentlicht: (2008)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
von: Osbak, K, et al.
Veröffentlicht: (2009)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
von: Gloyn, A
Veröffentlicht: (2003)

The role of genetic variation in glucokinase and glucokinase regulatory protein in diabetes and related traits
von: Beer, N, et al.
Veröffentlicht: (2011)

Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
von: Christesen, H, et al.
Veröffentlicht: (2008)

Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.
von: Arden, C, et al.
Veröffentlicht: (2007)

Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
von: Beer, N, et al.
Veröffentlicht: (2011)

Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
von: Valentinova, L, et al.
Veröffentlicht: (2011)

Persistent hyperinsulinemic hypoglycemia in a 7 yr old girl due to a novel activating glucokinase mutation
von: Lahr, G, et al.
Veröffentlicht: (2007)

Insights into glucokinase regulatory protein regulation from the cellular and kinetic characterisation of rare coding variants
von: Rees, MG, et al.
Veröffentlicht: (2010)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
von: Valentinova, L, et al.
Veröffentlicht: (2012)

Sulphonylureas and hypoglycaemia.
von: Ferner, R, et al.
Veröffentlicht: (1988)

Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
von: Gasperikova, D, et al.
Veröffentlicht: (2008)

Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
von: Wabitsch, M, et al.
Veröffentlicht: (2007)

Insulinoma - Presenting with reactive hypoglycaemia rather than fasting hypoglycaemia
von: Kar, P, et al.
Veröffentlicht: (2006)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
von: Rees, MG, et al.
Veröffentlicht: (2014)

Molecular basis of Kir6.2 mutations causing neonatal diabetes and neonatal diabetes with neurological features
von: Proks, P, et al.
Veröffentlicht: (2005)

Genetics for Endocrinologists: The Molecular Genetic Basis of Endocrine Disorders.
von: McCarthy, M, et al.
Veröffentlicht: (2003)

Hypoglycaemia in clinical diabetes /
von: Frier, Brian M, et al.
Veröffentlicht: (2007)

Functional characterisation of the glucokinase regulatory protein gene variant P446L shows diminished regulation by fructose-6 phosphate resulting in increased glucokinase activity
von: Beer, N, et al.
Veröffentlicht: (2009)

Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
von: Rees, MG, et al.
Veröffentlicht: (2013)

Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?
von: Rees, MG, et al.
Veröffentlicht: (2014)

Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.
von: Flanagan, SE, et al.
Veröffentlicht: (2006)

Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
von: Proks, P, et al.
Veröffentlicht: (2004)

Defining the genetic aetiology of monogenic diabetes can improve treatment.
von: Gloyn, A, et al.
Veröffentlicht: (2006)

Hypoglycaemia in paediatric admissions in Mozambique.
von: Solomon, T, et al.
Veröffentlicht: (1994)